All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @faadovale on TikTok · 94s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @faadovale's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00We are going to have a great video on this channel.
  2. 0:02I thought it was a big moment in which I decided to do this first show.
  3. 0:07I'm going to have more solutions.
  4. 0:08I'm going to get more energy that I can do more and more.
  5. 0:13I'm going to have more energy from the people in the world.
  6. 0:17I'm going to be talking about the world in the future.
  7. 0:20I'm going to give you the opportunity to make a video of the people who are playing.
  8. 0:26I think this one is probably too strong for me,
  9. 0:30this place.
  10. 0:32I think that theán did not care about how to do that.
  11. 0:36So, it is a really good place,
  12. 0:38but the only way is to do that person.
  13. 0:41And there is nothing there to say.
  14. 0:46I know.
  15. 0:47I have been on the street from France.
  16. 0:49And that is where we have come from.
  17. 0:54I was in the area where I was.
  18. 0:57and it's going to fall.
  19. 0:59It's going to have to have a vision at first.
  20. 1:01Thank you.
  21. 1:03I mean, this is a big question that we would like to talk about by anyone else.
  22. 1:07It's not cheap.
  23. 1:11For the first time, it's not a long time ago.
  24. 1:15I was like, I could have moved a little bit,
  25. 1:18and cervical pain,
  26. 1:20but I would have to let them feel good.
  27. 1:22and I would like to thank you for your support.
  28. 1:26I hope you enjoy this video.
  29. 1:28I hope you enjoy this video.
  30. 1:29I hope you enjoy this video.
  31. 1:30Thank you for watching and see you in the next video.

@faadovale's first-time Oestrogel use, fact-checked

Faa

TikTok creator

188.3K viewsWatch on TikTok

Quick answer

The creator is initiating Oestrogel (topical estradiol gel) as part of an apparent gender-affirming hormone regimen, also referencing Perlutan, a progestin injectable. The transcript is heavily obscured by translation artifacts, limiting clinical assessment, but the creator notes feeling the product may be 'too strong,' which could reflect rapid transdermal absorption or an inappropriately high starting application. No mention of lab monitoring, prescribing clinician, or serum estradiol targets appears in the video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @faadovale's first-time Oestrogel use, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@faadovale's first-time Oestrogel use, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@faadovale's first-time Oestrogel use, fact-checked" from Faa. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is initiating Oestrogel (topical estradiol gel) as part of an apparent gender-affirming hormone regimen, also referencing Perlutan, a progestin injectable.

The reason this review is not generic is the source wording and the canonical claim label "trt tomando oestrogel pela primeira vez trans oestrogel." In this clip, the useful excerpt is: "We are going to have a great video on this channel." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Endocrine Society's 2017 Clinical Practice Guideline (Hembree et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is initiating Oestrogel (topical estradiol gel) as part of an apparent gender-affirming hormone regimen, also referencing Perlutan, a progestin injectable.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is initiating Oestrogel (topical estradiol gel) as part of an apparent gender-affirming hormone regimen, also referencing Perlutan, a progestin injectable. The transcript is heavily obscured by translation artifacts, limiting clinical assessment, but the creator notes feeling the product may be 'too strong,' which could reflect rapid transdermal absorption or an inappropriately high starting application. No mention of lab monitoring, prescribing clinician, or serum estradiol targets appears in the video.
  • Oestrogel is a regulated estradiol gel (0.06%) approved for menopausal therapy and used off-label in GAHT; it is not equivalent to compounded estradiol gel products, which differ in concentration and absorption.
  • The Endocrine Society's 2017 Clinical Practice Guideline (Hembree et al., Journal of Clinical Endocrinology and Metabolism) recommends serum estradiol targets of 100-200 pg/mL for feminizing therapy, achievable only with lab monitoring.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Oestrogel is a regulated estradiol gel (0.06%) approved for menopausal therapy and used off-label in GAHT; it is not equivalent to compounded estradiol gel products, which differ in concentration and absorption.
  • The Endocrine Society's 2017 Clinical Practice Guideline (Hembree et al., Journal of Clinical Endocrinology and Metabolism) recommends serum estradiol targets of 100-200 pg/mL for feminizing therapy, achievable only with lab monitoring.
  • Getahun et al. (2018, Annals of Internal Medicine) found transgender women on feminizing hormones had a significantly higher venous thromboembolism risk, making baseline and follow-up labs a clinical necessity, not optional.
  • Estradiol's reported energy and vitality benefits are real but partially mood-mediated according to Seal (2017, British Medical Bulletin); expecting a direct physiological energy boost misrepresents the mechanism.
  • Transdermal estradiol absorption varies by application site, skin hydration, and individual metabolism, meaning subjective feelings of intensity do not reliably indicate whether serum levels are therapeutic, subtherapeutic, or elevated.
  • The creator's instinct to flag that the product felt 'too strong' reflects appropriate self-monitoring, but that observation should prompt a conversation with a prescribing clinician and a serum estradiol test, not just a content note.
  • Videos tagged as GAHT guidance reach large audiences actively seeking information; the absence of any safety or monitoring content in a 188K-view first-use video represents a meaningful information gap for viewers making clinical decisions.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @faadovale actually say?

Honestly? Not much that's medically substantive. The transcript is largely incoherent, likely a poor auto-translation from Portuguese. The clearest claims are that the creator is using Oestrogel for the first time, expects "more energy," and notes the product "is probably too strong" for them. There's also a passing mention of "cervical pain." That's about it for clinical content.

The video is tagged with #oestrogelhormoniotrans and #perlutan, suggesting this is a gender-affirming hormone therapy (GAHT) context, not traditional TRT for hypogonadism. Oestrogel is a topical estradiol gel, and Perlutan is an injectable progestin. Together, they form a common feminizing hormone regimen. The creator appears to be sharing a personal milestone, not giving medical advice, which is worth acknowledging upfront.

Does the science back up the energy claim?

The claim that estradiol will deliver "more energy" is partially supported, but it's more complicated than that framing suggests. The relationship between exogenous estradiol and energy is dose-dependent, bidirectional, and highly individual.

Research published by Newson et al. (2020, Post Reproductive Health) found that estradiol therapy improved self-reported fatigue in perimenopausal women, but effects were inconsistent across populations. For transgender women specifically, Seal (2017, British Medical Bulletin) noted that while GAHT often improves psychological wellbeing and reported vitality, the mechanism is partly mood-mediated, not purely physiological energy metabolism. Estradiol does interact with mitochondrial function, but calling that "more energy" oversimplifies what is a nuanced neuroendocrine effect. The creator's enthusiasm is understandable. The framing is just imprecise.

What did they get right, and what's missing?

Credit where it's due: flagging that the product felt "probably too strong" is actually a reasonable and responsible instinct. Oestrogel is a transdermal estradiol gel, and absorption rates vary significantly based on application site, skin hydration, and individual metabolism. Starting doses feeling intense is a documented phenomenon.

What's missing entirely is any discussion of monitoring. Estradiol therapy, particularly in a GAHT context without physician oversight, carries real risks that a 188K-view video should probably address. Estradiol increases thromboembolic risk, particularly at higher serum levels. The STRONG study (Getahun et al., 2018, Annals of Internal Medicine) found transgender women on feminizing hormones had a significantly elevated venous thromboembolism risk compared to cisgender controls. No mention of labs, serum estradiol targets, or clinical follow-up appears anywhere in this video. That's a gap worth naming plainly.

What should you actually know about Oestrogel and GAHT?

Oestrogel (estradiol gel 0.06%) is a legitimate, regulated pharmaceutical used both for menopausal hormone therapy and, off-label in many jurisdictions, for gender-affirming care. It is not the same as compounded estradiol gels, which vary in concentration and absorption profile. Do not assume equivalency between products.

For anyone considering or currently using Oestrogel as part of GAHT, the clinical standard of care involves baseline and follow-up labs: serum estradiol, testosterone, prolactin, liver function, and a complete metabolic panel. The Endocrine Society's 2017 Clinical Practice Guideline (Hembree et al., Journal of Clinical Endocrinology and Metabolism) recommends serum estradiol levels between 100 and 200 pg/mL as a general target range for feminizing therapy, with individualized adjustments. Self-dosing based on how something "feels" without lab confirmation is not a safe substitute for monitored care.

The cervical pain mention in the transcript is too unclear to assess, but any new pain following hormone initiation should be evaluated by a clinician, not ignored.

The bottom line on this video

This is a personal milestone video, not a medical guide, and it shouldn't be judged as one. But given 188K views and hashtags that function as a search destination for people starting GAHT, the absence of any safety information matters. The energy claims are loosely plausible but oversimplified. The instinct to flag feeling "too strong" is actually good self-awareness. What's absent is any roadmap for responsible use: get labs, work with a provider, know your targets. That context would have made this video genuinely useful instead of just relatable.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Faa · TikTok creator

188.3K views on this video

Tomando oestrogel pela primeira vez. . . #trans #oestrogel #oestrogelhormoniotrans #thresultados #transantesedepois #travesti #perlutan

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about oestrogel?

Oestrogel is a regulated estradiol gel (0.06%) approved for menopausal therapy and used off-label in GAHT; it is not equivalent to compounded estradiol gel products, which differ in concentration and absorption.

What does the video say about the endocrine society's 2017 clinical practice guideline (hembree et al.,?

The Endocrine Society's 2017 Clinical Practice Guideline (Hembree et al., Journal of Clinical Endocrinology and Metabolism) recommends serum estradiol targets of 100-200 pg/mL for feminizing therapy, achievable only with lab monitoring.

What does the video say about getahun et al. (2018, annals of internal medicine) found transgender?

Getahun et al. (2018, Annals of Internal Medicine) found transgender women on feminizing hormones had a significantly higher venous thromboembolism risk, making baseline and follow-up labs a clinical necessity, not optional.

What does the video say about estradiol's reported energy?

Estradiol's reported energy and vitality benefits are real but partially mood-mediated according to Seal (2017, British Medical Bulletin); expecting a direct physiological energy boost misrepresents the mechanism.

What does the video say about transdermal estradiol absorption varies by application site, skin hydration,?

Transdermal estradiol absorption varies by application site, skin hydration, and individual metabolism, meaning subjective feelings of intensity do not reliably indicate whether serum levels are therapeutic, subtherapeutic, or elevated.

What does the video say about the creator's instinct to flag?

The creator's instinct to flag that the product felt 'too strong' reflects appropriate self-monitoring, but that observation should prompt a conversation with a prescribing clinician and a serum estradiol test, not just a content note.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Faa, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.